Glaxosmithkline Share Price | |
---|---|
Price | 1,773.50 |
Bid | 1,772.00 |
Ask | 1,772.50 |
Change | 12.50 (0.71%) |
Volume | 6,684,121 |
Open | 1,770.00 |
High | 1,776.00 |
Low | 1,766.00 |
Prev. Close | 1,761.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.08b |
Market Capitalisation | £72.32b |
Market Size | 1,500 |
52 Week High | 1,776.00 |
52 Week High Date | 08-May-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 6,772 |
---|---|
Vol. Sold | 1,170,331 |
Sold Value | £20.73m |
Vol. Bought | 4,096,972 |
Bought Value | £72.65m |
PE Ratio | 14.5847 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.129% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
08-May-24 | 17:46:25 | 1,773.37 | 2,013 | Buy* | 1,772.00 | 1,772.50 | 35.70k | O Ordinary |
08-May-24 | 17:46:25 | 1,773.37 | 535,722 | Buy* | 1,772.00 | 1,772.50 | 10m | O Ordinary |
08-May-24 | 17:46:25 | 1,773.37 | 2,941 | Buy* | 1,772.00 | 1,772.50 | 52.15k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 5,009 | Buy* | 1,772.00 | 1,772.50 | 88.83k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 4,159 | Buy* | 1,772.00 | 1,772.50 | 73.76k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 140,465 | Buy* | 1,772.00 | 1,772.50 | 2m | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 3,528 | Buy* | 1,772.00 | 1,772.50 | 62.57k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 20,195 | Buy* | 1,772.00 | 1,772.50 | 358.16k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 8,797 | Buy* | 1,772.00 | 1,772.50 | 156.01k | O Ordinary |
08-May-24 | 17:44:42 | 1,773.50 | 3,170 | Buy* | 1,772.00 | 1,772.50 | 56.22k | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Vishal Sikka held the position of Independent Non-Executive Director at the time of this trade.Vishal Sikka | 40.96 | USD | 43 | 253,466,508 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Jesse Goodman held the position of Independent Non-Executive Director at the time of this trade.Jesse Goodman | 40.96 | USD | 9 | 11,157 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
At GSK, we unite science, technology and talent to get ahead of disease together